Mycoplasma DNA Detection Kit (qPCR), BP-QN22
Detects Mycoplasma DNA contamination by probe-based qPCR.

Product overview
This reagent kit uses the PCR-fluorescence probe method to design specific primers and probes for the conserved regions of Mycoplasma 16S rRNA sequence, which can specifically amplify Mycoplasma DNA with the characteristics of easy operation, rapid detection, strong specificity and high sensitivity.
Features and applications
- Simple operation: The workflow from sample extraction through completion of testing takes only 1.5 hours.
- Sensitivity: The limit of detection reached 5 CFU/mL in a matrix containing 10⁶ cells/mL. The study included the Mycoplasma species required by European Pharmacopoeia 12, Section 2.6.7.
- Precision: Intermediate precision (Ct value) CV ≤5%.
- Specificity: No cross-reactivity with common cell lines and structurally related microorganisms.
- Internal control: An internal control (IC) can be added during sample extraction to evaluate the extraction efficiency or during PCR amplification to monitor whether there is inhibition in the amplification reaction, thus preventing false negative results.
- Contamination control: This reagent kit contains UDG enzyme to prevent contamination of amplified products.
- Applicable devices: Including but not limited to SLAN-96P and SLAN-96S fully automated medical PCR analysis systems; ABI7500 and ABI QuantStudio™ 5 real-time fluorescent quantitative PCR systems; Roche LightCycler 480 fluorescent quantitative PCR system; and Bio-Rad CFX96 quantitative PCR system.
- The kit is used for qualitative detection of Mycoplasma DNA contamination in cells, cell and gene therapy products, and other biological products.
Components
| Components | Specification/Notes |
|---|---|
| My qPCR MIX | 1.0 mL x 1 tube |
| My Positive Control | 1.5 mL x 2 tubes |
| My Negative Control | 1.5 mL x 2 tubes |
| My Internal Control | 1.0 mL x 1 tube |
| Instructions | 1 copy |
Performance data
qPCR Sensitivity Verification
Table 1. Summary of Limit-of-Detection Data for 10 Common Standard Mycoplasma Strains
| Manufacturer | Strain | Catalog No. | Lot No. | Positive/total |
|---|---|---|---|---|
| Minerva Biolabs | Acholeplasma laidlawii | 102-8003 | 102-060-2404 | 24/24 |
| Mycoplasma fermentans | 102-6003 | 102-202-2406 | 24/24 | |
| Mycoplasma hyorhinis | 102-7003 | 102-591-2404 | 24/24 | |
| Mycoplasma orale | 102-2003 | 102-590-2405 | 24/24 | |
| Mycoplasma pneumoniae | 102-4003 | 102-911-2417 | 24/24 | |
| Mycoplasma gallisepticum | 102-3003 | 102-817-2402 | 24/24 | |
| Mycoplasma synoviae | 102-5003 | 102-430-2404 | 24/24 | |
| Mycoplasma arginini | 102-1003 | 102-129-2311 | 24/24 | |
| Spiroplasma citri | 102-9003 | 102-846-2404 | 24/24 | |
| Mycoplasma salivarium | 102-1103 | 102-113-2311 | 24/24 |
At 5 CFU/mL, the kit detected every standard Mycoplasma strain in 24 of 24 tests.
Cross-Reactivity Results
Cross-reactivity was evaluated using structurally related microorganisms and commonly used cell lines. DNA from 27 panel-listed items (CHO, Vero, E. coli, Sf9, MDCK, HEK293T, SP2/0, MDBK, PK15, CRFK, LLC-MK2, C6, MRC-5, Pichia pastoris, Lactobacillus acidophilus, Candida albicans, Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus epidermidis, Streptococcus pneumoniae, Staphylococcus aureus, Streptococcus mutans, Monascus purpureus, Salmonella enterica, Staphylococcus intermedius, Enterobacter aerogenes, and Streptococcus agalactiae) showed no cross-reactivity with the Mycoplasma detection reagent. The results are shown in Table 2.
Table 2. Cross-Reactivity Results
| Sample | FAM | VIC | Sample | FAM | VIC | ||||
|---|---|---|---|---|---|---|---|---|---|
| CHO | NoCt | NoCt | 30.45 | 30.05 | A. baumannii | NoCt | NoCt | 29.62 | 29.82 |
| Vero | NoCt | NoCt | 30.32 | 30.27 | P. aeruginosa | NoCt | NoCt | 29.94 | 29.73 |
| E. coli | NoCt | NoCt | 30.44 | 30.09 | S. epidermidis | NoCt | NoCt | 29.67 | 29.99 |
| Sf9 | NoCt | NoCt | 30.25 | 29.91 | S. pneumoniae | NoCt | NoCt | 29.57 | 29.55 |
| MDCK | NoCt | NoCt | 30.25 | 29.95 | S. aureus | NoCt | NoCt | 29.43 | 29.63 |
| HEK293T | NoCt | NoCt | 30.20 | 30.13 | S. mutans | NoCt | NoCt | 29.60 | 29.86 |
| SP2/0 | NoCt | NoCt | 30.22 | 30.22 | M. purpureus | NoCt | NoCt | 29.58 | 30.00 |
| MDBK | NoCt | NoCt | 30.19 | 30.28 | S. enterica | NoCt | NoCt | 29.56 | 29.99 |
| PK15 | NoCt | NoCt | 29.98 | 29.62 | S. intermedius | NoCt | NoCt | 30.13 | 30.33 |
| CRFK | NoCt | NoCt | 30.12 | 29.50 | E. aerogenes | NoCt | NoCt | 29.86 | 30.43 |
| LLC-MK2 | NoCt | NoCt | 29.59 | 29.42 | S. agalactiae | NoCt | NoCt | 30.24 | 30.30 |
| C6 | NoCt | NoCt | 30.05 | 29.42 | M. orale | 27.28 | 27.49 | 30.15 | 29.78 |
| MRC-5 | NoCt | NoCt | 29.59 | 29.41 | M. hyorhinis | 27.52 | 27.62 | 29.99 | 30.08 |
| P. pastoris | NoCt | NoCt | 29.68 | 29.69 | M. pneumoniae | 27.30 | 27.43 | 30.00 | 30.14 |
| L. acidophilus | NoCt | NoCt | 29.98 | 29.58 | Positive control | 26.57 | 26.87 | 30.14 | 30.43 |
| C. albicans | NoCt | NoCt | 29.69 | 29.54 | Negative control | NoCt | NoCt | 30.14 | 30.21 |
Conclusion:
DNA from the 27 panel-listed items (CHO, Vero, E. coli, Sf9, MDCK, HEK293T, SP2/0, MDBK, PK15, CRFK, LLC-MK2, C6, MRC-5, P. pastoris, L. acidophilus, C. albicans, A. baumannii, P. aeruginosa, S. epidermidis, S. pneumoniae, S. aureus, S. mutans, M. purpureus, S. enterica, S. intermedius, E. aerogenes, and S. agalactiae) showed no cross-reactivity with the Mycoplasma detection reagent.
Bioinformatics Analysis
Sequence alignment of the amplification target against the NCBI database indicated coverage of more than 200 Mycoplasma species.
Precision
Within-Run Precision
In-house reference materials Z1, Z2, and Z3 were tested in 10 replicates each. Precision CV was within 5% at every concentration.
Intermediate Precision
Intermediate precision was evaluated across operators, days, instruments, and reagent lots using in-house reference materials Z1, Z2, and Z3, with five replicates per material. Precision CV was within 5% at every concentration.
Total Imprecision
Data across operators, days, instruments, and reagent lots were pooled. Precision CV was within 5% at every concentration.
Performance data shown here were obtained with the reference materials, extraction workflows, instruments and acceptance criteria used in BIORI’s product-specific validation study. Users should verify performance in their own sample matrix and workflow.
Shipping and storage
| Condition | Recommendation |
|---|---|
| Storage | ≤-20°C, protected from light. Shelf life: 24 months. Avoid more than 10 freeze-thaw cycles. |
| Shipping | Ship frozen using dry-ice or validated frozen cold-chain packaging to maintain required frozen-storage conditions. |
| Handling | Protect from light and avoid unnecessary freeze-thaw cycles where applicable. |
Downloads
Need this product lyophilized, in bulk, or in a custom format?
The feasibility assessment is free of charge. Send the assay brief and target format.




